Popular topics to explore
CUPID
Financial performance and key Operating Metrics (Consolidated) :
Operating Revenue for Q1FY27 is Rs. 155 Crs., 158.72% growth YoY, Total Income is Rs. 157 Crs., 142.44% growth YoY, Gross Profit is Rs. 90 Crs., 151.89% growth YoY, EBITDA is Rs. 60 Crs., 264.85% growth YoY, EBITDA Margin is 38.82% improved by 1129 basis points YoY, PBT Rs. 60 Crs., 206.5% growth YoY, PAT Rs. 44 Crs. 194.14% growth YoY.
On QoQ basis Operating Revenue is up by 28.97%, Total Income is also up by 18.89%, Gross Profit is up by 37.71%, EBITDA is up by 60.1%, PBT is up by 26.28% and PAT is also up by 21.76%.
During FY26, the Company's Consumer Healthcare & FMCG portfolio contributed revenue of ₹121.61 crore.
The Company's international B2B healthcare business continued to witness robust demand across PFSCM, WHO/UNFPA, institutional procurement programmes, government tenders and private export markets, providing strong order visibility and a healthy revenue pipeline.
The Company has enhanced its FY27 guidance to ₹725 Cr - ₹750 Cr in revenue and ₹210 Cr - ₹225 Cr in Net Profit, supported by a strong order book, sustained momentum across its international B2B healthcare business and continued expansion of its Consumer Healthcare & FMCG portfolio.#FundamentalViews#WatchOutFor#EquityResearch#MacroViews#TrendingSectors
549 likes·60 comments

















